부산대학교 도서관

The article focuses on the challenges of managing osteoporosis in patients undergoing dialysis due to chronic kidney disease, emphasizing the increased fracture risk and limited treatment options. Topics include the emergence of denosumab as a potential treatment, and the significant risk of hypocalcemia associated with its use in dialysis patients, prompting the need for careful monitoring and development of multifaceted approaches to fracture prevention in this population.